The U.S. Federal Trade Commission found that a handful of the biggest pharmacy benefit managers have made huge profits at the expense of smaller pharmacies and consumers.
The consolidation of pharmacies and health insurance companies through years of deal making has led to a handful of pharmacy benefit managers exercising outsized influence over prescription drug prices, the U.S. Federal Trade Commission said on Tuesday.
